ACS SCHB abstracts acs 246nm Indianapolis Meeting
Upcoming SlideShare
Loading in...5
×
 

ACS SCHB abstracts acs 246nm Indianapolis Meeting

on

  • 447 views

Abstracts of the SCHB at the ACS 246th National Meeting in Indianapolis

Abstracts of the SCHB at the ACS 246th National Meeting in Indianapolis

Statistics

Views

Total Views
447
Views on SlideShare
444
Embed Views
3

Actions

Likes
0
Downloads
0
Comments
0

1 Embed 3

http://www.freelook.tv 3

Accessibility

Categories

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    ACS SCHB abstracts acs 246nm Indianapolis Meeting ACS SCHB abstracts acs 246nm Indianapolis Meeting Document Transcript

    • American Chemical Society 246th National Meeting Indianapolis, Indiana September 8-12, 2013 Division of Small Chemical Businesses ABSTRACTS OF ORAL PAPERS & POSTERS SUNDAY AFTERNOON Small Business Chemistry in Motion G. Arnold, Organizer, Presiding; Paper 1 MONDAY MORNING SCHB Poster Session G. Ruger, Organizer, Presiding; Papers 2-4 MONDAY EVENING Sci-Mix G. Ruger, Organizer; Papers 2-4 TUESDAY MORNING True Stories of Success from Chemical Entrepreneurs G. Ruger, Organizer, Presiding, Papers 5-10 TUESDAY AFTERNOON STEM Women in Innovation and Investing J. Bryant, Organizer; J. Maclachlan, Organizer; J. Giordan, Presiding; Papers 11-14 WEDNESDAY MORNING Applications of Ionic Liquids from the Small Business Sector S. Seelig, Organizer, Presiding; Papers 15-19 WEDNESDAY AFTERNOON Biofuels in Motion K. Andrews, Organizer, Presiding; Papers 20-22
    • SCHB 1 Business of science: How to turn your scientific skill set into a successful business enterprise Gianna Arnold1, Garnold@saul.com, Jacqueline L. Allen1, Elizabeth Hart Wells2, Rajesh Nair3, Linda Sivik4. (1) Saul Ewing LLP, Baltimore, MD 21202,(2) Kurz Purdue Technology Center, West Lafayette, IN 47906, (3) Saul Ewing LLP, Washington, DC 20006, (4) The Procter & Gamble Company, Cincinnati, OH 45202. Join our wide spectrum of speakers for a facilitated presentation and discussion aimed at assisting you with the business of science. The session will begin with “Best Steps to Business Success - and Pitfalls to Avoid,” an overview on creating a technology-based company. Further presentation and discussion will include the elements: creating an organizational structure, various forms of intellectual property and their use as strategic business assets, roles an expert can fill as a consultant to an early stage company or as a scientific advisory board member, alternative forms of compensation as a consultant, key considerations in agreements, technology transfer, industry collaboration, and much more! This is your opportunity to ensure the success of your new or planned endeavor. SCHB 2 Ariadne: A next generation chemical inventory and ELN web application Valentin O Rodionov, info@moleculenix.com.Moleculenix LLC., United States. Keeping track of thousands of chemicals in a research lab is not a trivial task. Specialized inventory software does exist. However, such software is often focused squarely on regulatory compliance, and is perceived by end users as a burdensome layer of digital bureaucracy. Laboratories in academia are especially likely to keep vital inventory records in ordinary spreadsheets, or even on paper. Recently, we introduced Ariadne, a web application combining a chemical inventory with an electronic lab notebook (ELN). Ariadne assigns the location of every chemical semi-randomly, based on storage compatibility rules. The system reveals the item location only after the item has been checked out by the user. Mandatory checkout ensures item movement is tracked in real time, with no extra effort from users. Ariadne utilizes our JavaScript chemical structure editor, ChemWidget, to enable structure input in any web browser. This presentation will describe our experience in developing chemical software for the modern web. SCHB 3 Benefits of a Division of Small Chemical Businesses membership Jennifer L Maclachlan1, pidgirl@gmail.com, Stan Seelig1, Mukund Chorghade1, Sharon Vercellotti1, David Deutsch1, Joseph E Sabol1, Michael Haukaas1, Anis Rahman1, Ronald Versic1, Carlyn Burton1, George Ruger. (1) Division of Small Chemical Businesses, Sandwich, MA 02563. The ACS Division of Small Chemical Businesses Division (SCHB) has provided valuable member benefits and informative programming, featuring small businesses and with resources for small businesses, at ACS national and regional meetings, since 1977. SCHB member benefits include free membership for the first year, listing in the SCHB website members' directory of products and services, deeply discounted ACS national meeting expo booth space the Small Chemical Business Row, scholarship to the ACS Leadership Courses, the opportunity to shape and direct SCHB, and, the best of all: amazing networking opportunities in-person at ACS meetings and via SCHB's social media platforms (ACS Network, LinkedIn, Twitter and Facebook.) Patron [corporate] membership is also available. SCHB 4 Chemical professionals investing in chemical companies Mark Vreeke, sidwhite@tampabay.rr.com, Sid White, Judith Giordan.Chemical Angel Network, United States. The Chemical Angel Network (CaN) is a nationwide angel investing network for early stage chemical businesses (ie. businesses with a significant chemistry component). The CaN network offers chemists, chemical engineers, and chemical professionals a unique opportunity to participate in the growth of companies in the chemical and related industries. In addition to possibly significant financial upside opportunities, the CaN network encompasses several unique elements. We anticipate that a significant number of the qualified investors will be retired or semi-retired chemical professionals. In
    • addition to capital, the network will draw upon the retired and semi-retired member's unique experience and knowledge base to provide special due diligence, mentoring, contacts, and general technical expertise. Our hope is that CaN will become the smart capital choice for early stage chemical companies. SCHB 5 Surviving a start-up by innovation Anis Rahman, a.rahman@arphotonics.net.Applied Research & Photonics, Harrisburg, PA 17111 In today's world the name of the game is competition. Especially when the ever-changing world of technology is bringing the next best thing more often, making the state of the art a thing of past more quickly. However, innovation or having a new idea alone is never sufficient to build and survive a business. It is important to have a priori knowledge about how the new technology or the new product will attract target users. An important question is, “why people should consider this product?” So, the value proposition must be strong. At the same time diffusion of knowledge of the new technology to the target population is always a challenge. More often than not, new entrepreneurs lack the foresight, since “success” never is a straight line; as such a great deal of lessons must be learned the hard way. Some examples will be outlined from a start-up point of view. SCHB 6 Commercializing your research and finding focus for your start-up using the teachings of the NSF I-Corps program Andrew D Basner, adbasner@syr.edu.Department of Chemistry, Syracuse University, Syracuse, NY 13244 The National Science Foundation has supported science and engineering for many years. Some of this research has the potential for applications in the commercial world but commercialization is often not realized. To help foster this transition from research to a commercial product, the National Science Foundation developed the Innovation corps program. Over the course of an intensive 8 week program, our team talked to over 100 potential customers, defined and validated a value proposition for clear customer segments, identified revenue strategies and models, identified the correct channels for our technology, and met with key potential partners. The teaching team for the NSF I-Corps helped us identify key pitfalls that are common in technology based start- ups and led us to a single, clear, and focus scalable business model. A number of key ideas from this program can be used by anyone who is interested in commercializing their research or by anyone who is in the process of finding an ideal market segment to fit into. SCHB 7 HESI: Creating science-based solutions for a sustainable, healthier world Jennifer Young Tanir, jtanir@hesiglobal.org.ILSI Health and Environmental Sciences Institute, Washington DC, United States. The ILSI Health and Environmental Sciences Institute (HESI) was established in 1989 as a global branch of the International Life Sciences Institute (ILSI) to provide an international forum to advance the understanding of scientific issues related to human health, toxicology, risk assessment, and the environment. With a vision of creating science-based solutions for a sustainable, healthier world, HESI recognizes sustainability as vitally important as it identifies and resolves global health and environmemntal issues through engagement with scientists from academia, government and industry. As a non-profit organization, HESI provides a unique, objective forum for initiating dialogue among scientists with different perspectives and expertise from a range of sectors including pharmaceuticals, agricultural and industrial chemicals, personal care and consumer product, and others. HESI's broad scientific portfolio spans translational biology, new approaches and techniques, environmental toxicology, and risk assessment. Using a committee structure to engage scientists, supported by expert staff with advanced scientific degrees, HESI enables hundreds of scientists to work together to address public health needs, from 49 corporate sponsors, 70 universities, 32 government agencies (international, national, and state), foundations and non-governmental organizations, by a financially viable model. This presentation will highlight several of HESI's success stories.
    • SCHB 8 Building a microencapsulation company: A 35 year history of controlled release Ronald J Versic, Rversic@RTDodge.com Ronald T. Dodge Company, Dayton, OH 45459. In the spring of 1979 the author started out with USD 500 and a desire to build a company based upon the principles of (1) multiple microencapsulation capabilities, a desire to (2) manufacture microcapsules and (3) scientific soundness. The results for this international company are described along with the difficult path to the current business status. SCHB 9 History of NanoVir, LLC, a drug discovery company supported by the NIH and grown partly through interactions with academia James K Bashkin, bashkinj@umsl.edu Department of Chemistry, NanoVir, LLC, Saint Louis, MO 63121, United States Department of Chemistry & Biochemistry, Center for Nanoscience, University of Missouri-St. Louis, Saint Louis, MO 63121. NanoVir LLC is a company that was started jointly by a chemist (myself) located in St. Louis MO and a biologist (Dr. Chris Fisher) located in Kalamazoo MI. Our purpose was the discovery and development of antiviral agents suitable for therapy against high-risk, cancer-causing human papillomavirus (HPV). In order create the company, we co-wrote a Phase I small business proposal to the National Institutes of Health and also submitted a proposal to the Biosciences Research & Commercialization Center (BRCC) funded by the State of Michigan. We were successful with our first NIH proposal and the BRCC proposal, allowing us to begin work as a real company. Our headquarters and Biology Department are located at the Southwest Michigan Innovation Center in Kalamazoo. Since I had held the position of Research Associate Professor in Chemistry & Biochemistry at the University of Missouri-St. Louis, we were able to establish and grow the company under the STTR mechanism, with chemistry done under subcontract to the University. Now, after two Phase I and two Phase II NIH STTR grants, we have a large set of active compounds with IC50 values in the 8-40 nM range, and many more with IC50s below 100 nM. Furthermore, we have a pair of compounds in preclinical development and a significant patent estate. The basis of our work is the design, synthesis and testing of sequence-selective DNA binding molecules that target key interactions between viral proteins and the viral genome, which is a double-stranded circular DNA molecule of about 8 kb. Chemistry and biology have been tightly integrated throughout the entire program, and this has contributed significantly to success. For the purpose of animal studies, we have scaled up compound synthesis and have tested a wide range of formulations on differentiated human tissue cultures, organotypic cultures, grown from keratinocyte monolayers. SCHB 10 50 years of success at Nice Pak Products Rick West, rick.west@nicepak.com.Nice Pak Products, Orangeburg, NY 10962. Nice Pak Products / PDI was started a little over 50 years ago by the Julius family and is still privately owned today. During that time, it has grown from a one room operation in NYC to where it is today- locations in NY, IN, AR, and a facility currently being built in China. Nice Pak produces products for the healthcare sector and also for the household sector. Some of the more interesting product lines will be discussed. Currently, Nice Pak produces approximately three billion wipes a year. The relative volume of liquid batches produced and some annual chemical consumption data will be provided. Some of the company's success stories and a few difficulties will be discussed. SCHB 11 Challenges and opportunities in technology transfer: How are STEM women faring? Mary Foley Phillips, Mary.Phillips@oregonstate.edu.Office for Commercialization and Corporate Development Research Office, Oregon State University, Corvallis, OR 97331 As Associate Director for the Office for Commercialization & Corporate Development at Oregon State University (OSU), Dr. Mary Foley Phillips is responsible for overseeing the management of intellectual property and licensing of OSU inventions. Dr. Phillips will discuss her perspectives on the challenges and opportunities in technology transfer for commercializing technology, and will discuss her views and share insights on how women are faring and can continue to thrive in this environment.
    • SCHB 12 Challenges of starting (and growing) a start-up Nicola L. Pohl, npohl@indiana.edu.Chemistry, Indiana University, Bloomington, IN 47405. Starting a company is easier than growing it into a success. This talk will focus on the challenges encountered in founding LuCella Biosciences, Inc., a carbohydrate-focused biotechnology company that sprung out of university-related research. SCHB 13 Women-led ventures: Insights from the X Squared Angels Group Carol Clark, carolahclark@gmail.com X Squared Angels Group, Columbus, OH 43212. Carol Clark's entrepreneurial roots date back to 1981 when she and Fran Papalios co-founded MindLeaders, an online software training company that was sold in 2007. Taking what she learned, Carol became an angel investor and member of several well-known and influential angel groups, including the Ohio TechAngel Funds, Golden Seeds and Investors' Circle. One of latest endeavors is founding the X Squared Angels Group - focused on women-led ventures. Carol's background and perspective as both a female angel investor (who seriously intends to help other women) and as an entrepreneur will help you gain the insights you need to succeed - whether it is to move your idea ahead or to understand the roles you, as a women in STEM, can play in technology commercialization. Carol also currently serves on the College of Arts and Sciences Technology Review Board at the Ohio State University where ideas and inventions are vetted for commercialization. SCHB 14 Issues women face in research and commercialization from academia: Personal insights from a successful company founder Kathryn Uhrich, keuhrich@rutgers.edu.Mathematical & Physical Sciences (SAS), Rutgers University, Piscataway, NJ 08854 As Professor of Chemistry and Dean of Mathematical & Physical Sciences (SAS) at Rutgers University, Dr. Kathryn Uhrich's research focuses on synthesis and characterization of biocompatible, biodegradable polymers for medical, dental, cosmetic and personal care applications. In 2000 she co- founded Polymerix Corporation, a specialty pharmaceutical company developing and commercializing PolyNSAIDs as coatings for implanted medical devices, such as orthopedic implants, sutures, surgical meshes, coronary stents, and vascular grafts, as well as long-acting formulations for drug delivery. As a chemistry professor, dean and company founder, Dr. Uhrich has a unique perspective on the issues women face in research and commercialization from academia – and she will bring to the discussion her insights into how women can succeed on all of those fronts. SCHB 15 Green solvents and ionic liquids: A business venture for the global conservation of water Stanley S Seelig, SSSeelig@aol.com. Seelig and Associates, Lakeland, FL 33810. Over the last 50 years (or longer) many processes were defined as solvent or water processes (or solventless or waterless). The halogenated solvents were beneficial as excellent cleaners with recyclable and reclaimable processes but many had toxicity, ozone depletion or global warming issues. Then many companies switched back to water based processes only to have to deal with poor cleaning, waste streams, and excessive surfactants. Now there is an option to switch to green(er) solvents on a global basis. How can this approach lead to a successful business venture? We will discuss a number of green solvents and their processes and how they are changing the world away from excessive waste water streams and assisting to preserve the conservation of water. From laundry to dishwasher to toilets and more, closed-loop solvent processes are a wave in the future. Water treatment plants are working at maximum to keep up with technology. Green solvents can relieve some of that pressure. And small businesses will provide the answers.
    • SCHB 16 Separation of hydrocarbons from sand or other minerals using ionic liquids Paul Painter, pcp1@psu.edu, Bruce Miller, Aron Lupinsky, Maria Sobkowiak, Andrea Choperena, Nuerxida Pulati.The E&MS Energy Institute, Penn State University, University Park, PA 16802. The separation or extraction of hydrocarbons such as oil and bitumen from soil, sand, or other forms of mineral matter is a difficult and expensive process that also results in environmental problems associated with the disposal of waste products. For example, the separation of bitumen from tar or oil sands involves large amounts of energy and water. The process water generated in the separation is toxic to aquatic life and is a major environmental problem. Similarly, the oil and gas industry has to deal with oil contaminated sand, waste drilling muds and drill cuttings in its operations. We have developed a novel method for separating bitumen, oil or other hydrocarbons from sand or soils through the use of ionic liquids (ILs). The separation occurs at ambient temperatures and does not result in the generation of significant quantities of waste process water. A preliminary patent application and a continuation in part describing the use of analogue ILs has been filed by the Penn State Research Foundation (PSRF) and a small company, IL Fuels LLC, founded to develop the technology. The company was granted an exclusive license to the technology from PSRF in exchange for a 5% equity stake. Some investment funds have been raised and a small pilot/demonstration unit built at Penn State. Potential licensees are now using the pilot unit for tests. Conversations with other potential investors and the patent office have been interesting. The presentation will elaborate on the problems we have faced. SCHB 17 Production of ionic liquid based electrolytes for electrochemical storage devices Joe C Poshusta, joe.poshusta@boulderionics.com. Boulder Ionics, Arvada, CO 80007. Ongoing research and development in electrochemical storage devices strives to improve their capacity, longevity, environmental resilience, and safety. With their wide electrochemical window and low vapor pressure, electrolytes containing room temperature ionic liquids are a key enabling technology common to all of these improvements. Electrochemical device applications impose stringent purity requirements on the electrolyte in order to maintain device lifetime. In particular, halide and water contamination cannot be tolerated above a few ppm by weight. Conventional ionic liquid synthesis often involves solvent based reactions, halide intermediates, and repetitive batch-wise purification to achieve electrochemical device requirements. While able to synthesize a wide variety of ionic liquids, these labor intensive and time consuming methods drive up cost, leading many device manufacturers to reject ionic liquids. Boulder Ionics has developed alternative synthetic routes adapted to scalable continuous processing techniques that can provide electrochemical grade ionic liquids in system residence times of just minutes. While vastly reducing labor cost, the continuous approach also enables tight process control and minimizes product handling, producing a high purity material. Ionic liquids and salts of interest for electrochemical devices include the fluorinated anioIns bis(trifluoromethyl sulfonyl)imide (TFSI) and bis(fluorosulfonyl)imide (FSI). These anions are often paired with pyrolidinium and imidazolium based cations in ionic liquids, while their lithium salts are useful in lithium and lithium-ion batteries. The TFSI anion has been commercially available for several years, but its cost can dominate the ionic liquid material cost. We have developed a scalable synthetic route to the much less expensive FSI anion, while at the same time proving to meet performance requirements as demonstrated by our development partners and other researchers. This presentation will review some of the performance capabilities of FSI based ionic liquids in electrochemical storage devices as well as discuss synthetic approaches to manufacturing related electrolyte systems. SCHB 18 Using academic resources to expand your chemical enterprise: Graphenics, LLC example Rachel M Frazier1,2, rmfrazier@bama.ua.edu, Hunter Adams2, Dan T Daly1. (1) Alabama Innovation and Mentoring of Entrepreneurs, The University of Alabama, Tuscaloosa, AL 35487, (2) Graphenics, LLC, Tuscaloosa, AL 35487. Ionic liquids (ILs) have numerous applications, making them ideal materials for platform technologies. A key challenge to any new material is advancing from the laboratory to the marketplace, thereby bridging the gap from proof-of-concept to prototype. ILs are no exception to this process, thus we explore the developmental part Alabama Innovation and Mentoring of Entrepreneurs (AIME) plays in
    • transitioning ILs from invention to innovation. We will explore the vital role AIME has played in helping to set up Graphenics, LLC for success. Exfoliation of graphite in ILs to produce graphene has been identified as having significant potential for success and AIME has assisted in developing the technology beyond proof-of-concept. We will present the translation of this technology from academia to the marketplace and a case study of a new chemical enterprise, Graphenics. Graphenics, LLC provides graphene materials and consulting services to both academia and industry. Graphenics core strength is the expertise in the exfoliation of graphite and the know-how of the proprietary process technology. SCHB 19 Novel chitin fibers for wound care Robin D Rogers, rdrogers@as.ua.edu, Gabrielle Gurau.AIME, University of Alabama, Tuscaloosa, AL 35405. 525 Solutions, Inc., a faculty start-up incubated at The University of Alabama with a mission to transfer fundamental research into new business enterprises while providing opportunities for students and staff to become entrepreneurs, proposes to use the newly discovered property of ionic liquids (ILs; salts which melt below 100 oC) to dissolve high molecular weight chitin directly from biomass to design novel composite fibers of natural polymers with embedded additives to improve the immune system and facilitate wound healing. 525 Solutions, Inc., will use the proprietary process to directly dissolve biopolymers (e.g., chitin, alginate, etc.) with or without functional additives into homogeneous solutions which will allow for the direct dry-jet wet spinning of composite materials. SCHB 20 CO2 recycling using microalgae for the production of liquid fuels M. M Crocker1, mark.crocker@uky.edu, M.H.W. Wilson1, J. Groppo1, A. Placido1, S. Graham1, A. Santillan-Jiminez1, T. Morgan1, J. Shoup1, D. Kim1, L. Mills1, H. Y Shin1, C. Crofcheck2. (1) Center for Applied Energy Research, University of Kentucky, Lexington, KY 40511, (2) Department of Biosystems & Agricultural Engineering, University of Kentucky, Lexington, KY 40511. Given the potential of microalgae for recycling CO2 into bio-products, coupled with the large number of coal-fired power plants in Kentucky, the Commonwealth of Kentucky's Department of Energy Development and Independence tasked the University of Kentucky with determining the technical and economic feasibility of algae-based carbon capture and utilization in Kentucky. These research efforts have led to the development and on-going deployment of a pilot-scale photobioreactor system at Duke Energy's East Bend station. This pilot-scale project is focused on process development/improvement, power plant integration, and the implementation of strategies to increase algae growth rates. The system is continuously monitored and the process data analyzed to gain insights into system dynamics and to improve the operation/design of future units. In tandem, we have developed a protocol for the harvesting and dewatering of algae (with minimal energy input) based on flocculation-sedimentation. Methodologies have also been developed for lipid extraction (from dry and wet algal biomass) and for the conversion of extracted lipids to liquid hydrocarbons by means of catalytic deoxygenation. SCHB 21 Microflotation for microorganism harvest James O. Hanotu, j.hanotu@sheffield.ac.uk, William B.J. Zimmerman.Perlemax Ltd., Sheffield, United Kingdom. Microbial cells or microorganisms are grown in bioreactors under conditions where they thrive and flourish, yielding a wide range of desired end products. Yeast, Bacteria and Algae are some of the most widely explored microorganisms and have been applied for food, water remediation and biofuel production. After the appropriate number of generations, the mature cell mass is separated from the spent liquid, then delivered as liquid cream, filtered, and sold as compressed forms or filtered and dried into instant dry cells. On occasions when a heterogeneous community is cultured, selective harvesting can possibly be employed to recover only the desired organism(s). The conventional approach to extracting cells from their growth medium is by centrifugation and filtration. However, these methods are expensive and often unsuitable for continuous large-scale production. Conversely, traditional flotation separation techniques (such as Dissolved Air Flotation) are regarded as both intrusive and energy intensive, and are only naturally suitable for portable water treatment. Our microflotation technique is advantageous due to its laminar flow process, its non-intrusiveness, and scalability to meet continuous industrial production
    • requirements. The efficacy of microflotation has been demonstrated for algal biomass recovery, as well as for yeast, showing optimum recovery rates comparable to ideal flotation separation results. SCHB 22 Integrated energy parks as a model for rural economic development and energy diversification in the Appalachian coalfields Roger Ford1, roger.ford@patriotbioenergy.com, Eric Mathis2. (1) Patriot Bioenergy Corporation, Pikeville, KY 41501, (2) Emergy Holdings, Inc., Williamson, WV 25661. Patriot Bioenergy Corporation and Emergy Holdings, Inc. have developed a business model that provides diversified energy production on post-mining land in the Appalachian coalfields termed Integrated Energy Parks. Through integration of energy resources, the business model couples solar, natural gas, and biomass to generate electricity and to produce energy-related products on post-mining land. As a start-up, we discuss the challenges associated with regulatory barriers and construction of such facilities, as well as the discussion of the dynamics that move us toward energy diversification and integration in the heart of the Appalachian coalfields. Issues discussed include production of sufficient biomass feedstock, post-mining land use, market-based sustainability strategies, and adoption of an 'all-of-the-above' energy policy framework. - NOTES -